JPMorgan Chase & Co’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3K | Sell |
13,750
-30
| -0.2% | -$121 | ﹤0.01% | 5063 |
|
|
2025
Q1 | $47.8K | Buy |
13,780
+409
| +3% | +$1.42K | ﹤0.01% | 5049 |
|
|
2024
Q4 | $88K | Buy |
13,371
+3,093
| +30% | +$20.4K | ﹤0.01% | 4820 |
|
|
2024
Q3 | $92.9K | Buy |
10,278
+5,915
| +136% | +$53.5K | ﹤0.01% | 4759 |
|
|
2024
Q2 | $70K | Sell |
4,363
-1,590
| -27% | -$25.5K | ﹤0.01% | 4772 |
|
|
2024
Q1 | $93.3K | Buy |
5,953
+5,841
| +5,215% | +$91.6K | ﹤0.01% | 4759 |
|
|
2023
Q4 | $1.5K | Buy |
+112
| New | +$1.5K | ﹤0.01% | 5733 |
|